Georgia is getting $5 million of a $389 million settlement from Bristol-Myers Squibb Co. and its former subsidiary Apothecon Inc., ending allegations the company participated in inappropriate marketing and pricing practices, the Georgia Department of Community Health reported Monday.
Lawyer Central Also Recommends These Stories: